Faculty

Institution

Unit

Venue

Roi Weiser

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Division Of Internal Medicine

Department Of Dermatology

Department Of Head And Neck Surgery

Division Of Surgery

Department Of Infectious Diseases

Division Of Internal Medicine

Division Of Cancer Medicine

Department Of Melanoma Medical Oncology

Department Of Melanoma Oncology

Section Of Hepato-Pancreato-Biliary

Department Of Surgical Oncology

Division Of Surgery

Department Of Surgical Oncology

Department Of Surgical Oncology, Section Of Surgical Endocrinology, United States

Division Of Surgical Oncology

The University of Texas MD Anderson Cancer Center

NoneRoi Weiser is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Roi Weiser

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology surgical oncology surgery breast cancer melanoma radiation oncology cancer care cancer research gynecology cancer treatment breast surgery pathology gynecologic oncology molecular cancer oncogenes cancer imaging breast oncology skin cancer gynecologic cancers plastic surgery cancer genetics therapeutic targets clinical research pancreatitis ovarian cancer jama oncology cancer management cancer genomics systemic therapy intraoperative consultation gynecological surgery clinical radiation oncology radiation therapy mucosal melanoma cancer cells gastrointestinal endoscopy digestive endoscopy leukemia brain tumor research medicinal research cellular therapy reconstructive microsurgery colorectal cancer cancer biology interventional endoscopy biliary tract eus-guided gastroenterostomy photocarcinogenesis clinical therapeutics anti-cancer agents genitourinary cancers endocrine-related cancers hormonal receptor pancreatic surgery hematological malignancies allelic variant microrna detection liver cancer clinical surgery disease detection cancer detection human tumor microbiome resectable mucosal melanoma src inhibition synergistic therapy prioritization cautionary tale ncdb analysis endoscopic retrograde tertiary center recurrence score invasive lobular carcinoma adjuvant chemotherapy effective systemic therapies evolving practice management malignant melanoma resected stage

Notable Scholarly Works

Notable Federal Grants

Collaborators

CORRECTION: Real-World Outcomes for Patients With Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. Annals of Surgical Oncology (2026)

radiation oncologynodal dissectioncancer immunotherapysurgical oncologymelanomadermatologycancer imagingdermatological surgerycancer careoncologyreal-world outcomes

Germline Variants in Cancer Susceptibility Genes Among Patients With Mucosal Melanoma. npj Genomic Medicine (2026)

melanomageneticshuman geneticscancer geneticscancer genomicsgenome biology

Real-World Outcomes for Patients With Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. Annals of Surgical Oncology (2026)

nodal dissectionsurgerycancer immunotherapysurgical oncologymelanomaimmunotherapydermatologyskin cancercancer careoncologyreal-world outcomes

Abstract Ct243: Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma. Cancer Research (2025)

oncogenesradiation oncologytumor biologyskin cancerdermatologyphase 2abstract ct243cancer researchcancer geneticsjama oncologycancer treatmentcancer letteroncology

Delineating the Role of the Microbiome and Tumor Microenvironment Interactions Driving Mucosal Melanoma (MM) Response and Resistance to Immune Checkpoint Inhibitor (Ici) Treatment.. Journal of Clinical Oncology (2025)

tumor microenvironment interactionscancer immunotherapyimmunologymelanomaimmunotherapydermatologymolecular cancergut microbesimmunomodulationimmune responsesmucosal melanomacancer immunosurveillancecheckpoint inhibitorimmune checkpoint inhibitorstumor microenvironment

Neoadjuvant-Adjuvant Pembrolizumab in Clinical Stage Iib/C Melanoma.. Journal of Clinical Oncology (2025)

John MiuraMohammad Saad FarooqPhyllis A. GimottyTara C. MitchellRavi K. AmaravadiLynn M. SchuchterSheryl MitnickXiaowei XuAlexander Chan Chi HuangMichael A. DaviesRodabe Navroze AmariaJason Alan ChesneyRoi WeiserJeffrey E. GershenwaldKelly McMastersGiorgos Constantine Karakousis

gliomascarcinogenesissystemic therapytherapeutic targetsbreast cancerkidney cancercell biologyoncogenesmedicinal researchmicrorna detectioncellular therapyurologyneurologyliver cancerhematological malignanciesbrain tumor researchallelic variantneoadjuvant-adjuvant pembrolizumableukemia

Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma. Practical Radiation Oncology (2025)

clinical radiation oncologyradiation therapyradiation oncologyprimary cutaneous melanomasurgerysurgical oncologymelanomadermatologyskin cancercancer imagingdermatological surgeryradiationoncology

Systemic Therapy for Melanoma. Surgical Oncology Clinics of North America (2025)

melanomadermatologydermatological treatmentsystemic therapysystemic treatmentoncology

The Era ‘or Error’ of Second Localization Procedures. Preprints.org (2025)

linguisticslanguage documentationlocalizationregional studiessecond localization procedureslanguage localisationlocalization technique

Clinical Outcomes for Brca Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation. JAMA Network Open (2024)

Kerollos Nashat WanisHenry M. KuererSusie X. SunKelly K. HuntAlexa C. GlencerMediget TeshomeAnthony LucciRoi WeiserHelen JohnsonBenjamin D. SmithAngelica M. GutierrezSimona F. ShaitelmanBanu K. Arun

clinical outcomesbreast conservationhealth sciencesbreast cancer

1
2
3
4
10 / page

Roi Weiser

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Division Of Internal Medicine

Department Of Dermatology

Department Of Head And Neck Surgery

Division Of Surgery

Department Of Infectious Diseases

Division Of Internal Medicine

Division Of Cancer Medicine

Department Of Melanoma Medical Oncology

Department Of Melanoma Oncology

Section Of Hepato-Pancreato-Biliary

Department Of Surgical Oncology

Division Of Surgery

Department Of Surgical Oncology

Department Of Surgical Oncology, Section Of Surgical Endocrinology, United States

Division Of Surgical Oncology

The University of Texas MD Anderson Cancer Center

NoneRoi Weiser is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Roi Weiser

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

CORRECTION: Real-World Outcomes for Patients With Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. Annals of Surgical Oncology (2026)

radiation oncologynodal dissectioncancer immunotherapysurgical oncologymelanomadermatologycancer imagingdermatological surgerycancer careoncologyreal-world outcomes

Germline Variants in Cancer Susceptibility Genes Among Patients With Mucosal Melanoma. npj Genomic Medicine (2026)

melanomageneticshuman geneticscancer geneticscancer genomicsgenome biology

Real-World Outcomes for Patients With Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. Annals of Surgical Oncology (2026)

nodal dissectionsurgerycancer immunotherapysurgical oncologymelanomaimmunotherapydermatologyskin cancercancer careoncologyreal-world outcomes

Abstract Ct243: Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma. Cancer Research (2025)

oncogenesradiation oncologytumor biologyskin cancerdermatologyphase 2abstract ct243cancer researchcancer geneticsjama oncologycancer treatmentcancer letteroncology

Neoadjuvant-Adjuvant Pembrolizumab in Clinical Stage Iib/C Melanoma.. Journal of Clinical Oncology (2025)

Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma. Practical Radiation Oncology (2025)

clinical radiation oncologyradiation therapyradiation oncologyprimary cutaneous melanomasurgerysurgical oncologymelanomadermatologyskin cancercancer imagingdermatological surgeryradiationoncology

Systemic Therapy for Melanoma. Surgical Oncology Clinics of North America (2025)

melanomadermatologydermatological treatmentsystemic therapysystemic treatmentoncology

The Era ‘or Error’ of Second Localization Procedures. Preprints.org (2025)

linguisticslanguage documentationlocalizationregional studiessecond localization procedureslanguage localisationlocalization technique

Clinical Outcomes for Brca Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation. JAMA Network Open (2024)

Kerollos Nashat WanisHenry M. KuererSusie X. SunKelly K. HuntAlexa C. GlencerMediget TeshomeAnthony LucciRoi WeiserHelen JohnsonBenjamin D. SmithAngelica M. GutierrezSimona F. ShaitelmanBanu K. Arun

clinical outcomesbreast conservationhealth sciencesbreast cancer

1
2
3
4
10 / page